{"type":"doc","content":[{"type":"paragraph","content":[{"type":"text","text":"The "},{"type":"text","marks":[{"type":"bold"}],"text":"Optimum Patient Care Research Database (OPCRD)"},{"type":"text","text":" is a leading UK electronic medical record (EMR) database, owned and maintained by "},{"type":"text","marks":[{"type":"bold"}],"text":"Optimum Patient Care Limited (OPCUK) "},{"type":"text","text":"and an EHDEN data partner, having completed the OMOP CDM mapping in 2023 (v5.4.1). With de-identified health information from over 27 million patients across 1,175+ primary care sites, OPCRD offers an unparalleled resource for healthcare research and innovation. Its extensive dataset includes a wide range of patient information, including demographics, diagnoses, symptoms, treatments, test results, referrals, and patient-reported outcomes, providing insights into approximately 37% of the UK population."}]},{"type":"paragraph","content":[{"type":"text","text":" "}]},{"type":"paragraph","content":[{"type":"text","text":"Approved for use by the NHS Health Research Authority (HRA) Research Ethics Committee (REC Reference: 20/EM/0148), OPCRD is a trusted resource for medical research, underpinning over 110 published studies in clinical care, public health, and pharmaceuticals. The database is overseen by an independent committee, ensuring ethical, secure, and compliant use of anonymised data for research purposes."}]},{"type":"paragraph","content":[{"type":"text","text":" "}]},{"type":"paragraph","content":[{"type":"text","text":"OPCUK also owns and maintains global databases that would enrich the research beyond OPCRD."}]},{"type":"bulletList","content":[{"type":"listItem","content":[{"type":"paragraph","content":[{"type":"text","text":"International Severe Asthma Registry: 34,000+ patients from more than 250 sites across 32 countries"}]}]},{"type":"listItem","content":[{"type":"paragraph","content":[{"type":"text","text":"OPCRD-Australia: 950,000+ patients across 22 primary care sites"}]}]},{"type":"listItem","content":[{"type":"paragraph","content":[{"type":"text","text":"OPCRD-US: 120 sites across 3 integrated healthcare systems"}]}]}]}]}
Price D, Jenkins C, Hancock K, Vella R, Heraud F, Le Cheng P, Murray R, Beekman M, Bosnic-Anticevich S, Botini F, Carter V, Catanzariti A, Doan J, Fletton K, Kichkin A, Le T, Le Lievre C, Lau CM, Novic D, Pakos J, Ranasinghe K, Roussos A, Samuel-King J, Sharma A, Stewart D, Willet B, Bateman E, OPCA Improving Asthma Outcomes in Australia Research Group.
Price D, Henley W, Cançado JED, Fabbri LM, Kerstjens HAM, Papi A, Roche N, Şen E, Singh D, Vogelmeier CF, Nudo E, Carter V, Skinner D, Vella R, Soriano JB, Kots M, Georges G.
Kerr M, Tarabichi Y, Evans A, Mapel D, Pace W, Carter V, Couper A, Drummond MB, Feigler N, Federman A, Gandhi H, Hanania NA, Kaplan A, Kostikas K, Kruszyk M, van Melle M, Müllerová H, Murray R, Ohar J, Pollack M, Pullen R, Williams D, Wisnivesky J, Han MK, Meldrum C, Price D.
